Restless Legs: Causes, Symptoms, and Relief Options

Restless legs syndrome (RLS) is a neurological condition driven primarily by disrupted dopamine signaling and, in many cases, low iron levels in the brain. It affects roughly five to ten percent of the general population and produces an uncomfortable urge to move the legs that strikes during rest, worsens at night, and eases with movement. Despite how common it is, RLS was largely dismissed as a quirky complaint until surprisingly recently, and it remains underdiagnosed today, particularly in children and people with conditions that mask it.

How RLS Is Recognized

A diagnosis rests on four clinical criteria established by a National Institutes of Health consensus panel: you feel an urge to move your legs, usually accompanied by unpleasant sensations; the urge begins or worsens during periods of rest or inactivity; movement partially or completely relieves it; and symptoms are worse in the evening or at night, or only occur during those hours.¹ All four must be present. No blood test or brain scan confirms RLS on its own. The diagnosis is entirely based on what you describe to a clinician.

The sensations people report vary widely. Some describe a crawling feeling deep inside the calves; others call it a pulling, throbbing, or aching. A few say it feels like insects moving under the skin. The common thread is that lying still becomes intolerable. You feel compelled to get up, walk around, or at least flex your legs, and the moment you do, the discomfort fades. Then you sit or lie down again, and it comes back.

One pitfall in diagnosis is that these four criteria can overlap with other conditions. Painful diabetic neuropathy, for instance, also causes leg discomfort that worsens at rest, and people with diabetes develop RLS at higher-than-average rates, making it tricky to sort out which condition is responsible for which symptoms.² Leg cramps, positional discomfort, and arthritis pain can also mimic the pattern.³ The circadian element, that symptoms reliably peak in the evening and at night, is often the detail that separates genuine RLS from look-alikes.

The Iron-Dopamine Connection

Two biological threads run through almost all RLS research: dopamine signaling in the brain is disrupted, and brain iron levels are often low, even when standard blood tests come back normal. These two problems are connected, because iron is a required cofactor for the enzyme that produces dopamine. When the brain does not have enough iron, dopamine production and regulation suffer.

Imaging and cerebrospinal fluid studies consistently show that people with RLS have reduced iron and ferritin in the brain, particularly in the substantia nigra, a region central to dopamine activity.⁴ This brain iron deficit can exist independently of what is happening in the rest of the body; your blood iron panel may look perfectly fine while the transport mechanisms that move iron across the blood-brain barrier are not working efficiently.⁵ Newer research has found that neurons in people with RLS may actually shed iron-loaded particles, further depleting their own intracellular iron stores.⁶

On the dopamine side, brain-imaging meta-analyses show decreased functional connectivity in the dopaminergic pathways of people with RLS, including the circuits responsible for movement planning and sensory processing.⁷ Studies of immune cells in RLS patients have found lower expression of D2 dopamine receptors, suggesting the underactivity extends beyond the brain.⁸ The picture that emerges is not simply “too little dopamine” but rather a system whose dopamine regulation is off-kilter, which is an important distinction when it comes to treatment.

Why Symptoms Peak at Night

One of the defining and most frustrating features of RLS is its circadian rhythm. You might feel perfectly fine all morning and afternoon, then start noticing symptoms as evening sets in. Research has explored several biological clocks that could drive this pattern, including daily fluctuations in iron availability, dopamine levels, core body temperature, and hormones like melatonin and thyroid-stimulating hormone.⁹

Among these, melatonin stands out. In a study that tracked RLS patients around the clock, the rise in melatonin secretion in the evening consistently preceded the worsening of leg discomfort and involuntary limb movements. Melatonin appears to inhibit central dopamine release, which could explain why symptoms hit hardest right when your body is preparing for sleep.¹⁰ This timing is what makes RLS such a potent sleep disruptor. The symptoms arrive precisely when you need to be still and relaxed.

Genetics and Family History

RLS runs in families. Early genetic studies identified a handful of chromosomal regions linked to the condition and pointed to an autosomal dominant inheritance pattern in some families, meaning a single copy of the risk variant from one parent could be enough to produce symptoms.¹¹ The strongest single genetic risk factor identified so far is a region near a gene called MEIS1 on chromosome 2.¹²

But the genetic landscape is far more complex than a single gene. A large genome-wide meta-analysis published in 2024 expanded the number of known risk loci eightfold to 164, including three on the X chromosome.¹³ That many loci spread across the genome suggest RLS is not a single-gene disorder but a condition shaped by many small genetic contributions, each nudging the risk up a bit. This fits the clinical picture well: some people have severe symptoms from adolescence, while others develop mild symptoms in middle age that slowly progress.

Secondary Causes and Triggers

Not all RLS is inherited. A range of medical conditions and medications can trigger or worsen it.

Kidney disease is one of the most well-established triggers. Among people on dialysis, the prevalence of RLS is roughly two to three times higher than in the general population, with most studies reporting rates between 15 and 30 percent.¹⁴ The proposed mechanism involves a combination of iron imbalance in the central nervous system, chronic inflammation, oxidative stress, and elevated phosphorus levels.¹⁵

Pregnancy is another common trigger. Symptoms tend to peak in the third trimester and usually resolve around delivery.¹⁶ In a prospective study that tracked pregnant women, more than half reported RLS onset before the 20th week, and both symptom severity and involuntary limb movements dropped by more than half after delivery.¹⁷ The likely culprits are the shifting iron demands of pregnancy and hormonal changes that affect dopamine.

Certain medications can also provoke or worsen RLS. Antidepressants are the most frequently discussed class. A systematic review found that while the overall rate of antidepressant-triggered RLS is uncommon, specific drugs, particularly mirtazapine and venlafaxine, were associated with higher rates of new or worsened symptoms.¹⁸ An analysis of two decades of FDA adverse-event reports confirmed that a wide range of medications can trigger RLS onset or make existing symptoms worse.¹⁹ If your symptoms appeared or escalated shortly after starting a new medication, that timing is worth mentioning to your doctor.

What RLS Does to Sleep and Overall Health

The most immediate consequence of RLS is disrupted sleep. Many people with RLS also experience periodic limb movements during sleep, which are repetitive, involuntary jerking or twitching motions of the legs that can fragment sleep without you fully waking up. These movements are not the same as RLS itself; periodic limb movements occur in other sleep disorders and even in healthy people, so they are not diagnostic on their own.²⁰ But when they coexist with RLS, the combination can devastate sleep quality.

Beyond poor sleep, mounting evidence ties RLS to cardiovascular risk. A study of middle-aged women found that those with frequent RLS symptoms (more than 15 episodes per month) had roughly 40 percent higher odds of hypertension compared to women without RLS, even after adjusting for other risk factors. Both systolic and diastolic blood pressure climbed in a dose-response pattern as symptom frequency increased.²¹ Separate research has found that RLS patients show abnormal 24-hour blood pressure patterns, including a reduced nighttime dip that is itself an independent cardiovascular risk factor.²² A 2025 review in JAMA reported that about 30 percent of people with RLS have coronary artery disease, stroke, or heart failure.²³ Whether RLS directly causes cardiovascular disease or simply shares risk factors with it is still debated, but the association is strong enough to warrant attention.

Mental Health and Quality of Life

RLS takes a toll that goes beyond physical discomfort and bad sleep. Depression rates among people with RLS hover around 30 percent, and observational studies support a bidirectional relationship: depression can worsen RLS, and RLS can worsen depression.²³ Anxiety is common as well. Perhaps more alarming, suicidal ideation appears at elevated rates in RLS patients, and recent work suggests this can persist even when depressive symptoms improve, meaning it may not be purely a secondary effect of feeling down.²⁴ If you or someone you know has RLS and is struggling emotionally, it is worth raising directly with a healthcare provider rather than assuming better sleep will fix everything.

Non-Drug Approaches That Have Evidence Behind Them

Several non-pharmacological strategies have been tested in randomized trials. A systematic review of these interventions found that exercise, compression devices, certain types of acupuncture, and repetitive transcranial magnetic stimulation all outperformed control conditions in reducing RLS severity. On the other hand, vibration pads, cryotherapy, and transcranial direct current stimulation did not show clear benefits for symptom severity, though some of these did improve sleep quality measures.²⁵

A more recent meta-analysis found that vibration and electrical stimulation devices produced a significant reduction in symptom severity, while the evidence for massage, cryotherapy, and exercise was less consistent. Sleep quality, measured by standardized questionnaires, improved across the board with non-drug interventions as a group.²⁶ Among hemodialysis patients specifically, an eight-week stretching exercise program significantly reduced RLS severity compared to a control group.²⁷

Practical takeaways from this evidence: regular leg stretching and moderate exercise are low-risk and have the most consistent support. Compression garments and pneumatic devices are worth trying. Hot or cold therapy and massage may improve sleep even if they do not reliably reduce the RLS sensations themselves. These approaches work best as complements to other treatment, not necessarily as replacements for medication in moderate-to-severe cases.

Iron Supplementation

Because brain iron deficiency is central to RLS in many patients, correcting iron levels is often the first medical step. An international task force guideline concluded that intravenous ferric carboxymaltose (a single high-dose infusion) is effective for moderate-to-severe RLS in people whose serum ferritin is below 300 micrograms per liter and can be used as a first-line treatment. Oral iron supplements are possibly effective for those with serum ferritin at or below 75 micrograms per liter.²⁸ A pilot randomized trial comparing intravenous and oral iron in people with iron-deficiency anemia and RLS found both routes produced marked symptom improvement, with no significant difference between them.²⁹

The important nuance here is the ferritin threshold. Many clinicians consider a ferritin above 20 or 30 “normal” for general health purposes, but in RLS treatment, most specialists aim for ferritin above 75, and ideally above 100, before concluding that iron supplementation is not going to help. If your ferritin was checked and deemed “fine” at 40, it may be worth revisiting.

Prescription Medications and the Augmentation Trap

When iron correction and non-drug strategies are not enough, two main medication classes are used: alpha-2-delta ligands (gabapentin enacarbil and pregabalin) and dopamine agonists (like pramipexole, ropinirole, and rotigotine patches). A comparative meta-analysis of 35 trials found that gabapentin enacarbil, pregabalin, and rotigotine were all similarly effective and all superior to placebo, with no significant differences among them.³⁰

The choice between these classes, however, is not a coin flip. A head-to-head trial comparing pregabalin with pramipexole found that pregabalin produced a greater reduction in symptom scores, and about 71 percent of people on pregabalin rated themselves much or very much improved, compared to about 47 percent on placebo. More critically, the rate of augmentation over a year was significantly lower with pregabalin than with the higher dose of pramipexole.³¹

Augmentation is the most important complication to understand if you are taking or considering dopamine-based treatment for RLS. It means the medication itself causes your symptoms to become worse than they were before you started treatment. Symptoms start appearing earlier in the day, spread to the arms, feel more intense, and the drug seems to require ever-increasing doses to keep working.³² The underlying mechanism likely involves dopamine agonists driving dopamine receptor desensitization and disrupting the brain’s natural dopamine regulation.³³ This is why many RLS specialists now favor alpha-2-delta ligands as the first prescription choice and reserve dopamine agonists for cases that do not respond, or use them at the lowest effective dose.

RLS in Children

RLS is not just an adult condition, but it is routinely missed in children. Kids often cannot articulate the distinctive RLS sensations in ways that map neatly to the adult diagnostic criteria, and their restlessness may be attributed to behavioral issues or growing pains. In a small but revealing study, 10 out of 11 children who had been diagnosed with “growing pains” actually met the clinical criteria for RLS, and six of those ten also had attention-deficit/hyperactivity disorder (ADHD).³⁴

A systematic review confirmed that pediatric RLS is comorbid with a number of both physical and neuropsychiatric conditions, and its atypical presentation in children contributes to underdiagnosis.³⁵ If a child complains of vague leg discomfort that reliably happens at bedtime, struggles to fall asleep, and has a family history of RLS, a conversation with a pediatric neurologist or sleep specialist can be worthwhile. Treatment in children typically begins with iron assessment, since iron deficiency is common in growing kids and is one of the most treatable contributors.

A Condition That Took Centuries to Be Taken Seriously

The symptoms now called restless legs syndrome were first described in print by the English physician Thomas Willis in 1685. For the next 260 years, the condition appeared only sporadically in medical literature and was mostly regarded as a curiosity. It was not until Swedish neurologist Karl-Axel Ekbom published a detailed clinical description in 1944 that RLS began to be treated as a legitimate medical entity.³⁶³⁷ Even after Ekbom’s work, skepticism persisted for decades. The condition’s subjective symptoms, lack of visible pathology, and circadian pattern made it easy for clinicians to dismiss. That long history of being ignored may explain why many people today still hesitate to mention their symptoms, or why some physicians still treat RLS as a minor nuisance rather than the neurological disorder it is. If your legs will not let you rest, the science says you are not imagining things.